RCW 69.41.120
Prescriptions to contain instruction as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted—Out-of-state prescriptions—Form—Contents—Procedure.
(1) Every drug prescription shall contain an instruction on whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted in its place, unless substitution is permitted under a prior-consent authorization.
If a written prescription is involved, the prescription must be legible and the form shall have two signature lines at opposite ends on the bottom of the form. Under the line at the right side shall be clearly printed the words "DISPENSE AS WRITTEN." Under the line at the left side shall be clearly printed the words "SUBSTITUTION PERMITTED." The practitioner shall communicate the instructions to the pharmacist by signing the appropriate line. No prescription shall be valid without the signature of the practitioner on one of these lines. In the case of a prescription issued by a practitioner in another state that uses a one-line prescription form or variation thereof, the pharmacist may substitute a therapeutically equivalent generic drug or interchangeable biological product unless otherwise instructed by the practitioner through the use of the words "dispense as written," words of similar meaning, or some other indication.
(2) If an oral prescription is involved, the practitioner or the practitioner's agent shall instruct the pharmacist as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted in its place. The pharmacist shall note the instructions on the file copy of the prescription.
(3) The pharmacist shall note the manufacturer of the drug dispensed on the file copy of a written or oral prescription.
(4) The pharmacist shall retain the file copy of a written or oral prescription for the same period of time specified in RCW 18.64.245 for retention of prescription records.
[ 2015 c 242 § 2; 2000 c 8 § 3; 1990 c 218 § 1; 1979 c 110 § 2; 1977 ex.s. c 352 § 3.]
NOTES:
Findings—Intent—2000 c 8: See note following RCW 69.41.010.
Structure Revised Code of Washington
Title 69 - Food, Drugs, Cosmetics, and Poisons
Chapter 69.41 - Legend Drugs—Prescription Drugs.
69.41.020 - Prohibited acts—Information not privileged communication.
69.41.032 - Prescription of legend drugs and dialysate by dialysis programs.
69.41.040 - Prescription requirements—Penalty.
69.41.042 - Record requirements.
69.41.050 - Labeling requirements—Penalty.
69.41.060 - Search and seizure.
69.41.062 - Search and seizure at rental premises—Notification of landlord.
69.41.065 - Violations—Juvenile driving privileges.
69.41.072 - Violations of chapter 69.50 RCW not to be charged under chapter 69.41 RCW—Exception.
69.41.075 - Rules—Availability of lists of drugs.
69.41.080 - Animal control—Rules for possession and use of legend drugs.
69.41.085 - Medication assistance—Community-based care setting.
69.41.095 - Opioid overdose reversal medication—Standing order permitted.
69.41.100 - Legislative recognition and declaration.
69.41.130 - Savings in price to be passed on to purchaser.
69.41.140 - Minimum manufacturing standards and practices.
69.41.150 - Liability of practitioner, pharmacist.
69.41.160 - Pharmacy signs as to substitution for prescribed drugs.
69.41.170 - Coercion of pharmacist prohibited—Penalty.
69.41.190 - Preferred drug substitution—Exceptions—Notice—Limited restrictions.
69.41.200 - Requirements for identification of legend drugs—Marking.
69.41.220 - Published lists of drug imprints—Requirements for.
69.41.230 - Drugs in violation are contraband.
69.41.240 - Rules—Labeling and marking.
69.41.260 - Manufacture or distribution for resale—Requirements.
69.41.320 - Practitioners—Restricted use—Medical records.
69.41.330 - Public warnings—School districts.